Ophthalmology · Brooklyn, NY
NPI
1972539112
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
384 Neptune Ave
Brooklyn, NY, 11235
Phone (718) 615-0020
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
22,773 services
Medicare patients, 2024
1,459
Average age 79
Drug cost, 2024
$2.0M
10,931 prescriptions
Company payments, 2025
$2,300
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stanley Bykov was code J2777 (injection, faricimab-svoa, 0.1 mg), 3,360 times for 11 patients. In total Stanley Bykov billed 22,773 services in 57 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 3,360 | 11 | $27.51 | $92K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,199 | 1,212 | $36.96 | $118K |
| 99213 Office E&M - Established | Office | 2,454 | 1,075 | $85.51 | $210K |
| 99214 Office E&M - Established | Office | 1,413 | 1,040 | $116.88 | $165K |
| 92285 Standard X-ray | Office | 1,158 | 1,091 | $21.77 | $25K |
| 92250 Angiography | Office | 1,108 | 1,081 | $32.54 | $36K |
| 92025 Test - Miscellaneous | Office | 1,107 | 1,092 | $32.79 | $36K |
| 76512 Ultrasound - Nonspecific | Office | 1,068 | 1,053 | $89.90 | $96K |
| 92020 Ophthalmological E&M | Office | 993 | 974 | $26.26 | $26K |
| 92083 Vision, Hearing, and Speech Services | Office | 910 | 871 | $61.27 | $56K |
| 67028 Intravitreal Injection | Office | 839 | 118 | $107.38 | $90K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 810 | 11 | $114.88 | $93K |
| 95004 Test - Miscellaneous | Office | 672 | 14 | $3.90 | $2,618 |
| J9035 Injection, bevacizumab, 10 mg | Office | 550 | 94 | $57.02 | $31K |
| 68761 Eye | Office | 512 | 182 | $105.31 | $54K |
By year: 2022 $1.2M for 17,300 services; 2023 $1.3M for 19,044 services; 2024 $1.6M for 22,773 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 290 | 145 | $22.03 | $6,389 |
Medicare prescription drug claims, 2024
In 2024, the drug Stanley Bykov prescribed most often to Medicare patients was Latanoprost, with 1,860 prescriptions and refills. In total Stanley Bykov wrote 10,931 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,860 | 1,937 | 260 | $8,329 |
| Ofloxacin Generic | 1,150 | 1,155 | 659 | $12K |
| Prednisolone Acetate Generic | 876 | 1,335 | 327 | $43K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 773 | 774 | 478 | $6,512 |
| Timolol Maleate Generic | 717 | 1,140 | 146 | $35K |
| Ketorolac Tromethamine Generic | 495 | 502 | 193 | $17K |
| Restasis Cyclosporine | 422 | 671 | 94 | $409K |
| Xiidra Lifitegrast | 392 | 410 | 92 | $273K |
| Erythromycin Erythromycin Base | 372 | 372 | 154 | $3,283 |
| Dorzolamide Hcl Generic | 254 | 375 | 53 | $3,288 |
| Brimonidine Tartrate Generic | 249 | 394 | 59 | $35K |
| Vyzulta Latanoprostene Bunod | 248 | 266 | 32 | $66K |
| Cyclosporine Generic | 216 | 308 | 54 | $85K |
| Simbrinza Brinzolamide/Brimonidine Tart | 205 | 266 | 44 | $40K |
| Azelastine Hcl Generic | 194 | 202 | 60 | $2,193 |
Brand drugs: 5,247 claims; generic drugs: 5,684 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stanley Bykov $2,300 ($2,300 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $539.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $539 |
| Bausch & Lomb Americas Inc. BLCO | 14 | $404 |
| Harrow Eye, LLC | 15 | $348 |
| Alcon Vision LLC ALC | 8 | $285 |
| Tarsus Pharmaceuticals, Inc. TARS | 8 | $207 |
| Thea Pharma Inc. | 5 | $110 |
| Apellis Pharmaceuticals, Inc. APLS | 3 | $91.03 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $68.33 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $60.57 |
| LKC Technologies, Inc. | 2 | $52.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.